Ann Dermatol.  2020 Feb;32(1):83-87. 10.5021/ad.2020.32.1.83.

Pityriasis Amiantacea: An Epidemiologic Study of 44 Cases in Korean Patients

• Kwak HB
• Yun SK
• Kim HU
• Park J

• KMID: 2467208
• DOI: http://doi.org/10.5021/ad.2020.32.1.83

Abstract

No abstract available.

MeSH Terms

Epidemiologic Studies*
Humans
Pityriasis*

Reference

1. Alibert JL. Monographie des dermatoses ou préćis théorique et pratique des maladies de la peau 1. Paris: Daynac;1832. p. 293–295.

2. Verardino GC, Azulay-Abulafia L, Macedo PM, Jeunon T. Pityriasis amiantacea: clinical-dermatoscopic features and microscopy of hair tufts. An Bras Dermatol. 2012; 87:142–145.

3. Collins CD, Hivnor C. Seborrheic dermatitis. In : Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill;2012. p. 263–264.

4. Abdel-Hamid IA, Agha SA, Moustafa YM, El-Labban AM. Pityriasis amiantacea: a clinical and etiopathologic study of 85 patients. Int J Dermatol. 2003; 42:260–264.

5. Hansted B, Lindskov R. Pityriasis amiantacea and psoriasis. A follow-up study. Dermatologica. 1983; 166:314–315.

6. Knight AG. Pityriasis amiantacea: a clinical and histopathological investigation. Clin Exp Dermatol. 1977; 2:137–143.

7. Ring DS, Kaplan DL. Pityriasis amiantacea: a report of 10 cases. Arch Dermatol. 1993; 129:913–914.

8. Bilgiç Ö. Vemurafenib-induced pityriasis amiantacea: a case report. Cutan Ocul Toxicol. 2016; 35:329–331.

9. Pham RK, Chan CS, Hsu S. Treatment of pityriasis amiantacea with infliximab. Dermatol Online J. 2009; 15:13.

10. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol. 1975; 64:401–405.